Miromatrix Announces Participation in the 20th Annual Craig-Hallum Institutional Investor Conference
30 Maggio 2023 - 10:05PM
Miromatrix Medical Inc. (NASDAQ: MIRO), a life sciences company
pioneering a novel technology for bioengineering fully
transplantable organs to help save and improve patients' lives,
announced that members of the management team will participate in
the upcoming 20th Annual Craig-Hallum Institutional Investor
Conference on May 31st, 2023. Due to the format of this event, no
webcast will be available.
About MiromatrixMiromatrix Medical Inc. is
a life sciences company pioneering a novel technology for
bioengineering fully transplantable human organs to help save and
improve patients' lives. The Company has developed a proprietary
perfusion technology platform for bioengineering organs that it
believes will efficiently scale to address the shortage of
available human organs. The Company's initial development focus is
on human livers and kidneys. For more information,
visit miromatrix.com.
Investor ContactGreg Chodaczek347-620-7010
ir@miromatrix.com
Media Contact:press@miromatrix.com
Grafico Azioni MiroMatrix Medical (NASDAQ:MIRO)
Storico
Da Apr 2024 a Mag 2024
Grafico Azioni MiroMatrix Medical (NASDAQ:MIRO)
Storico
Da Mag 2023 a Mag 2024
